Across many learning partnerships, Wharton has worked with leading pharmaceutical companies to create the following custom executive education programs:
- Wharton engaged with a large subsidiary of a top five global pharmaceutical company to craft and refine their overarching strategic direction. Over an intensive four-day session, the company's president and top 70 senior leaders worked intimately with Wharton faculty to craft the strategy and assign action steps for execution, given the current global environment and scenarios for the future.
- A global, rapidly growing specialty pharmaceutical company, which had achieved a $10 billion market capitalization in a decade, needed to build the leadership to drive its growth. Together with the firm’s senior executives, Wharton created a series of five-day programs to develop leadership skills, an entrepreneurial mindset, and interdisciplinary knowledge for a growing portfolio of businesses. More than 100 company leaders have completed the program, which covers strategy and execution, managing talent and culture, global biopharmaceutical trends, M&A issues, value creation, and managing across organizational boundaries.
- With rising costs of new drug launches and narrower windows to earn returns, a leading pharmaceutical company worked with Wharton to create a set of executive programs on value creation. More than 350 managers participated in the value creation seminars, which explored branding, finance, pharmacoeconomics and pricing, and scenario planning. Faculty used original case studies based on the company’s actual product launches, and at the end of the program participants presented their plans to senior executives. The value creation program was so successful that the company worked with Wharton to create a second program focusing on global positioning.
